# Replimune Group, Inc. (REPL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/REPL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -322.38M | $ -290.04M | $ 76.35M | $ 210.54M |
| 2024 | $ 0 | $ -239.90M | $ -201.78M | $ 76.04M | $ 482.37M |
| 2023 | $ 0 | $ -227.02M | $ -190.59M | $ 75.81M | $ 421.54M |
| 2022 | $ 0 | $ -175.10M | $ -135.15M | $ 60.40M | $ 595.35M |
| 2021 | $ 0 | $ -128.18M | $ -92.36M | $ 33.10M | $ 437.51M |
| 2020 | $ 0 | $ -95.75M | $ -75.78M | $ 33.42M | $ 516.20M |
| 2019 | $ 0 | $ -56.14M | $ -80.51M | $ 42.05M | $ 197.57M |
| 2018 | $ 0 | $ -40.98M | $ -32.13M | $ 4.97M | $ 143.24M |
| 2017 | $ 0 | $ -22.13M | $ -20.26M | $ 0 | $ 65.77M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.36 |
| Liabilities / Eq | 0.58 |
| Current Ratio | 5.60 |

## Other views

- [Metrics](https://sponda.capital/en/REPL.md)
- [Charts](https://sponda.capital/en/REPL/charts.md)
- [Compare](https://sponda.capital/en/REPL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.